FDA Approves First Rapid-Acting Insulin Biosimilar for Patients With Diabetes
2025-02-19
Merilog administered subcutaneously five to 10 minutes before mealtime helps improve glycemic controlContinue Reading
FDA Approves More Broadly Protective Meningococcal Vaccine
2025-02-18
Vaccine helps protect against the A, B, C, W, and Y serogroups of Neisseria meningitidisContinue Reading
U.S. Gambling Addiction Searches Soar With Legal Sports Betting
2025-02-17
MONDAY, Feb. 17, 2025 (HealthDay News) — Millions of Americans have sought help for gambling addiction in the wake of a 2018 U.S. Supreme Court decision that allowed states to legalize sports betting. That’s among the key findings in a new study published Feb. 17 in JAMA Internal Medicine. “Sportsbooks haveContinue Reading
Experts Warn Marijuana Ads Are Reaching Kids Through Social Media
2025-02-13
THURSDAY, Feb. 13, 2025 (HealthDay News) — A legal loophole is allowing marijuana ads to slip past regulations and land right in front of kids on social media, a new report shows. Although the federal Controlled Substances Act prohibits advertising the sale or use of marijuana through federal airwaves orContinue Reading
Senators Call on FDA to Act Against Misleading Weight-Loss Drug Commercials
2025-02-12
Direct-to-consumer telehealth company advertisement that aired during the Super Bowl failed to mention side effects of the drugsContinue Reading
FDA Approves Wearable Infusion Device for Advanced Parkinson Disease
2025-02-06
Onapgo is a subcutaneous apomorphine infusion device for the treatment of motor fluctuations in patients with advanced diseaseContinue Reading
FDA Approves Symbravo for Acute Treatment of Migraine in Adults
2025-02-05
Symbravo can rapidly eliminate migraine pain within two hours, with efficacy sustained through 24 and 48 hours, across migraine pain severityContinue Reading
FDA Approves Susvimo for Diabetic Macular Edema
2025-02-05
Approval marks the first and only continuous delivery treatment as an alternate to regular eye injectionsContinue Reading
Ozempic-Type Drug Fails To Slow Parkinson’s, Study Finds
2025-02-05
WEDNESDAY, Feb. 5, 2025 (HealthDay News) — Hopes that GLP-1 drugs such as Ozempic and Wegovy could help slow Parkinson’s disease have taken an hit. A new study found that a drug in the same class called exenatide, marketed as Byetta, had no effect on slowing the disease or easingContinue Reading
Many Americans Misguided On Daily Aspirin, Survey Finds
2025-02-04
TUESDAY, Feb. 4, 2025 (HealthDay News) — Many Americans don’t see anything wrong with taking daily low-dose aspirin, even though experts have concluded its risks outweigh its benefits, a new survey has found. Nearly half (48%) of people incorrectly think that the benefits of taking low-dose aspirin daily to reduceContinue Reading
Heart Patients Aren’t Taking Lifesaving Meds
2025-02-04
TUESDAY, Feb. 4, 2025 (HealthDay News) — Drugs like blood thinners, cholesterol-lowering statins and blood pressure meds can protect the health and extend the lives of people with heart disease. But only if patients take the drugs — and many around the world aren’t, a new study says. Overall, fewerContinue Reading
FDA Approves First New Non-Opioid Pain Pill in Decades
2025-01-31
FRIDAY, Jan. 31, 2025 (HealthDay News) — The U.S. Food and Drug Administration (FDA) has approved Journavx, a new pain reliever without the risks of addiction or overdose linked to drugs like Vicodin and OxyContin. The new pill, developed by Vertex Pharmaceuticals, is intended for short-term pain relief following surgeryContinue Reading
Daily Aspirin Reduces Colon Cancer Risk: Study
2025-01-29
WEDNESDAY, Jan. 29, 2025 (HealthDay News) — Daily low-dose aspirin can help prevent cancers from returning in about a third of colon cancer patients, a new study says. Taking 160 milligrams of aspirin a day cuts the risk of cancer recurrence in half among colon cancer patients with a mutationContinue Reading
COVID-19 Remains Major Health Threat in U.S.
2025-01-29
WEDNESDAY, Jan. 29, 2025 (HealthDay News) — COVID-19 continues to be a threat to America’s health, causing more illness and death than either influenza or respiratory syncytial virus (RSV), a new study suggests. COVID accounted for 3 of 5 (60%) respiratory illnesses among military veterans treated by the U.S. VeteransContinue Reading